28 related articles for article (PubMed ID: 3276979)
1. Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators.
Nayak S; Gowda J; Abbas SA; Kim H; Han SB
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140607
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.
Sjogren M; Hoofnagle JH
Gastroenterology; 1985 Aug; 89(2):252-8. PubMed ID: 4007416
[TBL] [Abstract][Full Text] [Related]
3. Predominance of immunoglobulin M antibody to hepatitis B core antigen in chronic carriers of hepatitis B surface antigen.
Sampliner RE; Schable CA
Am J Clin Pathol; 1984 Jan; 81(1):88-90. PubMed ID: 6691306
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin M antibody to hepatitis B core antigen and fulminant hepatitis B.
Gordon SC; Jeffers LJ; De Medina MD; Reddy KR; Schiff ER
Ann Intern Med; 1985 Mar; 102(3):415-6. PubMed ID: 3970491
[No Abstract] [Full Text] [Related]
5. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
6. IgM-antibody response to the hepatitis B core antigen in acute and chronic hepatitis B.
Tedder RS; Wilson-Croome R
J Hyg (Lond); 1981 Apr; 86(2):163-72. PubMed ID: 7462600
[TBL] [Abstract][Full Text] [Related]
7. What is the role of testing for IgM antibody to core antigen of hepatitis B virus?
Lemon SM
Mayo Clin Proc; 1988 Feb; 63(2):201-4. PubMed ID: 3276979
[No Abstract] [Full Text] [Related]
8. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
Weber B
Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
[TBL] [Abstract][Full Text] [Related]
9. [Current status of the problem of viral hepatitis B prophylaxis].
Golosova TV; Vlasikhina EM
Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
[No Abstract] [Full Text] [Related]
10. [Occurrence of HBV serological markers in patients with chronic hepatitis].
Cichoz-Lach H; Słomka M; Daniluk J; Celiński K; Pokora J
Pol Arch Med Wewn; 1992 Oct; 88(4):244-9. PubMed ID: 1488325
[No Abstract] [Full Text] [Related]
11. [Structure and function of hepatitis B virus proteins].
Loch T; Slusarczyk J
Pol Arch Med Wewn; 1987 Dec; 78(6):341-6. PubMed ID: 3078036
[No Abstract] [Full Text] [Related]
12. [What should a vaccine against hepatitis B be like?].
Anan'ev VA; Zhdanov VM
Vopr Virusol; 1978; (6):643-9. PubMed ID: 86238
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
